4
Changes in Ownership
REGENXBIO Inc. Filed Acc 0001562180-20-007249
President and CEO sold 4,500 shares at $40.00 ($180,000)
- President and CEO acquired 4,500 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Mills Kenneth T. · President and CEO
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-12-10 | Exercise or conversion : show line 1 in the form | +4,500 | $0.85 | $3,825 | 245,500 | D |
| 2020-12-10 | Sale : show line 2 in the form | −4,500 | $40.00 | $180,000 | 241,000 | D |
| Open-market sales · 4,500 sh · avg $40.00 · $180,000 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2020-12-10 | Exercise or conversion : show line 3 in the form Employee Stock Option (Right to Buy) | −4,500 | 75,170 | D |
Loading xslF345X03/primarydocument.xml…